Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2581 to 2595 of 7687 results

  1. Ovarian cancer QS update

    In development [GID-QS10182] Expected publication date: 05 February 2025

    Quality standard
    In development

  2. Obecabtagene autoleucel for treating relapsed or refractory B-cell acute lymphoblastic leukaemia [ID6347]

    In development [GID-TA11496] Expected publication date: 25 June 2025

    Technology appraisal guidance
    In development

  3. Artificial intelligence technologies to aid the opportunistic detection of vertebral fragility fractures on radiographic images

    Awaiting development [GID-HTE10059] Expected publication date: TBC

    Health technology evaluations
    Awaiting development

  4. Digital platforms to support cardiac rehabilitation

    Awaiting development [GID-HTE10060] Expected publication date: TBC

    Health technology evaluations
    Awaiting development

  5. Hydromethylthionine mesylate for treating mild cognitive impairment or mild or moderate dementia caused by Alzheimer's disease [ID6343]

    In development [GID-TA11379] Expected publication date: 30 April 2025

    Technology appraisal guidance
    In development

  6. Intravascular lithotripsy for calcified coronary arteries during percutaneous coronary intervention

    In development [GID-IPG10391] Expected publication date: 05 February 2025

    Interventional procedures guidance
    In development

  7. Zilucoplan for treating antibody positive generalised myasthenia gravis [ID4008]

    In development [GID-TA11096] Expected publication date: TBC

    Technology appraisal guidance
    In development

  8. Targeted Muscle Reinnervation for refractory pain after limb amputation

    In development [GID-IPG10369] Expected publication date: 20 June 2025

    Interventional procedures guidance
    In development

  9. Transcatheter aortic valve implantation for native aortic valve regurgitation

    In development [GID-IPG10357] Expected publication date: 11 June 2025

    Interventional procedures guidance
    In development

  10. Alcohol-mediated perivascular renal sympathetic denervation for resistant hypertension

    In development [GID-IPG10299] Expected publication date: 05 February 2025

    Interventional procedures guidance
    In development

  11. Corticosteroid-releasing bioabsorbable stent or spacer insertion during endoscopic sinus surgery to treat chronic rhinosinusitis

    In development [GID-IPG10392] Expected publication date: 05 February 2025

    Interventional procedures guidance
    In development

  12. Zilucoplan for treating antibody positive generalised myasthenia gravis [ID4008]: draft guidance

    We are listening to your views on this Technology appraisal guidance. Comments close 5 December 2024.

    Technology appraisal guidance
    In consultation

  13. Laparoscopic insertion of an inactive implant for gastro-oesophageal reflux disease

    In development [GID-IPG10345] Expected publication date: 17 April 2025

    Interventional procedures guidance
    In development

  14. Devices for remote monitoring of Parkinson's disease (DG51)

    Evidence-based recommendations on Kinesia 360 and KinesiaU (Great Lakes NeuroTechnologies), PDMonitor (PD Neurotechnology), Personal KinetiGraph (Global Kinetics) and STAT-ON (Sense4care) for remote monitoring of Parkinson’s disease

    Diagnostics guidance
    Last updated
    25 January 2024
    View recommendations

    Sections for DG51

  15. Therapeutic monitoring of TNF-alpha inhibitors in Crohn's disease (LISA-TRACKER ELISA kits, IDKmonitor ELISA kits, and Promonitor ELISA kits) (DG22)

    Evidence-based recommendations on therapeutic monitoring of tumour necrosis factor (TNF)-alpha inhibitors (LISA-TRACKER, IDKmonitor and Promonitor ELISA kits) in people with Crohn’s disease

    Diagnostics guidance
    Published
    17 February 2016
    View recommendations

    Sections for DG22